Wysenski Nancy
Transactions
50
Companies
10
Filings
15
CIK
0001294596
Recent Transactions
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Tax Payment
- Award
- Award
- Award
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Sale
- Exercise/Conversion
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Award
- Award
- Award
- Award
- Award
- Award
- Exercise/Conversion
- Tax Payment
- Exercise/Conversion
- Award
- Award
- Award
- Award
- Award
- Exercise/Conversion
- Tax Payment
- Exercise/Conversion
- Award
- Award
- Award
Companies
10- $ALKS
Alkermes plc.
Director
- $CYTK
CYTOKINETICS INC
Director
Dova Pharmaceuticals Inc.
Director
ENDO HEALTH SOLUTIONS INC.
Chief Operating Officer
Endo Pharmaceuticals Solutions Inc.
Director
- $INO
INOVIO PHARMACEUTICALS, INC.
Director
NORTH AMERICAN SCIENTIFIC INC
Director
Provention Bio, Inc.
Director
TETRAPHASE PHARMACEUTICALS INC
Director
- $VRTX
VERTEX PHARMACEUTICALS INC / MA
EVP & Chief Commercial Officer
Recent Filings
15- 4
Wysenski Nancy
Jan 16, 2026
- 4
Wysenski Nancy
Oct 16, 2025
- 4
Wysenski Nancy
Jul 16, 2025
- 4
Wysenski Nancy
May 14, 2025
- 4
Wysenski Nancy
Apr 16, 2025
- 4
Wysenski Nancy
Jan 6, 2025
- 4
Wysenski Nancy
Oct 3, 2024
- 4
Wysenski Nancy
Jul 3, 2024
- 4
Wysenski Nancy
May 16, 2024
- 4
Wysenski Nancy
Jan 3, 2024
- 4
Wysenski Nancy
Oct 3, 2023
- 4
Wysenski Nancy
Jul 10, 2023
- 4
Wysenski Nancy
Jul 5, 2023
- 4
Wysenski Nancy
Jun 30, 2023
- 4
Wysenski Nancy
May 18, 2023
Address
350 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA, 94080